Pharma Contract Development Manufacturing Organization & Contract Research Organization List

Solid Form CRO Services and Formulation CDMO Services

As a Leading Expert in Solid Form, Solid-State Research, Pre-formulation, Formulation Development and Manufacturing, Crystal Pharmatech is recognized for the professional, high-quality service, fast and efficient response.

We offer a wide range of technologies and service to tailor your needs to help you develop, manufacture, and innovate your small molecules at any stage of formulation development through our innovative technology, extensive experience and practical solutions.

Innovative Solutions

Mol2Med™ First-Time-Right 3-STEP Approach

Crystal Pharmatech are a specialized CRO/CDMO focused on Solid State Research, Pre-Formulation, Formulation Development and Manufacturing. Our strength is our focus and expertise in these specialties...

Developability Assessment

For lead compounds or candidate compounds, Crystal pharmatech can make an objective evaluation of the development potential and risks of drugs through comprehensive and accurate evaluation of the physicochemical properties of compounds, combined with a variety of mature development evaluation models and GastroPlus^® software.

API Form and Solid-State Research

Crystal Pharmatech employs an integrated approach to identify and develop the best crystal form for your small molecules through effective screening and rigorous assessments.

Crystallization Development

Based on in-depth research on the properties of the crystal form itself and the transformation relationship between crystal forms, Crystal Pharmatech can offer a robust and scalable crystallization process that yields a reproducible high-quality solid form.

Pre-formulation Studies

Crystal Pharmatech can bridge the gap between the API and formulation through our solid-state service, which can be seamlessly progressed into pre-formulation research while de-risking your assets.

Formulation and Analytical Development

Instead of one-size-fits-all platforms, Crystal Pharmtech applies a "First-Time-Right" strategy for formulation development to accelerate your molecule to First in Human (FIH) studies and onward to commercialization in a cost-effective and time-saving way.

GMP Manufacturing

Crystal Pharmatech offers a full spectrum of formulation manufacturing services covering a wide variety of dosage forms and meeting GMP requirements in the US, Europe and China.

Clinical Supply

Crystal Pharmatech provides a one-stop Clinical Supply Service from pre-clinical to post-marketing. Services provided:Primary packagingcGMP environment;cGMP requirements;Blistering, bottling, capsulat...

Competitive Advantages



Technical Strength

Strong technical team with >20 years of experience of delivering 100+ early phase and 30+ commercialized products at global pharma
Molecule-Material-Medicine (MMM) driven formulation strategy expertise in enabling preclinical formulation development
Specialize in mini-tablet pediatric formulation
QbD-based versatile and strong agile manufacturing capability



Platform Strength

Leverage all business units within Crystal Pharmatech



Equipment and Instrument Strength

Top-of-the-line equipment and notch instruments for DS/DP characterization and formulation technology



Systems Strength

cGMP facility and QMS that met NMPA, FDA, and EMA regulatory requirements
One-stop shop from preclinical to commercial manufacturing
Integrated clinical formulation development process from bulk manufacturing to packaging and supply

Proven Success for Partnership

For biotech, Crystal Pharmatech offers practical, innovative, cost-effective and comprehensive solutions from early development to GMP manufacturing. By utilizing our Molecule-Material-Medicine (MMM) approach, we work diligently with you to move your molecule to medicine faster with optimal API formulation and form.

Molecule-Material-Medicine (MMM) Approach

Molecule

Material

Medicine

Molecule

● Clinical info and needs

● DMPK understanding

● Pharmacodynamics

● Safety info

● Molecular profile

Material

● API phase

● API physiochemical,

biopharmaceutical, mechanical

properties and stability

● Excipient functionality, physical

attributes, compatibility

● Properties of formulation

tailored for process

Medicine

● Label as driver for design

● Interaction of composition and

process

● Impact of API(s) and excipients

properties and composition on

CQA

● Impact of CPP on CQA

● Control strategy for drug product

Want to Know More?

If you have any questions, we will always be happy to help. Feel free to contact us by telephone, mail or leave a message.



Telephone:

+1-609-604-8303



Mail:

bd_global@crystalpharmatech.com



Address:

Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey 08512, USA

By providing your e-mail address, you agree to receive an e-mail response from Crystal Pharmatech to your inquiry. The information you submit will be governed by our Privacy Policy.